Not applicableEnded earlyNCT04839601What this trial is testingRNS System RESPONSE StudyWho this might be right forEpilepsyPartial SeizureNeurostimulator; Complications+2 more NeuroPace 9
Large-scale testing (Phase 3)Study completedNCT02535091What this trial is testingSafety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset SeizuresWho this might be right forPartial Epilepsy SK Life Science, Inc. 1,345
Post-approval studies (Phase 4)Ended earlyNCT05684978What this trial is testingEfficacy and Safety of Perampanel in the Treatment of Refractory Status EpilepticusWho this might be right forRefractory Status Epilepticus Wayne State University 1
Not applicableActive Not RecruitingNCT05867160What this trial is testingAdjunctive Anti-seizure Medication (ASM) Real World Evidence (RWE) StudyWho this might be right forEpilepsy Aziende Chimiche Riunite Angelini Francesco S.p.A 300
Not applicableStudy completedNCT00001325What this trial is testingMetabolic Abnormalities in Children With EpilepsyWho this might be right forGeneralized EpilepsyInfantile SpasmsMetabolic Disease+2 more National Institute of Neurological Disorders and Stroke (NINDS) 80
Testing effectiveness (Phase 2)Study completedNCT00236873What this trial is testingThe Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.Who this might be right forEpilepsyEpilepsies, PartialSeizures Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Testing effectiveness (Phase 2)Ended earlyNCT04153175What this trial is testingStudy to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary GeneralizationWho this might be right forRefractory Epilepsy Cerebral Therapeutics LLC 30
Not applicableLooking for participantsNCT06716801What this trial is testingReal-world Clinical Response to Cenobamate Early add-on in France, Germany and SpainWho this might be right forFocal Epilepsy With and Without Secondary Generalization Aziende Chimiche Riunite Angelini Francesco S.p.A 300
Testing effectiveness (Phase 2)WithdrawnNCT00982787What this trial is testingSafety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial EpilepsyWho this might be right forPartial Epilepsy Oregon Health and Science University
Large-scale testing (Phase 3)Study completedNCT00988156What this trial is testingEslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in ChildrenWho this might be right forPartial Epilepsy in Children and Adolescents Bial - Portela C S.A. 304
Large-scale testing (Phase 3)Study completedNCT00655551What this trial is testingSafety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset SeizuresWho this might be right forPartial EpilepsiesPartial Onset Seizures UCB BIOSCIENCES, Inc. 100
Not applicableStudy completedNCT03082222What this trial is testingZEDEBAC: Zebinix Effects in Dependency of Baseline ConditionsWho this might be right forFocal Epilepsy Eisai GmbH 246
Testing effectiveness (Phase 2)Study completedNCT00236860What this trial is testingThe Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset SeizuresWho this might be right forEpilepsyEpilepsies, PartialSeizures Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 56
Post-approval studies (Phase 4)Not Yet RecruitingNCT06534502What this trial is testingStudy of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset SeizuresWho this might be right forSeizuresSeizures, FocalSeizure, Partial Onset+4 more Azurity Pharmaceuticals 40
Large-scale testing (Phase 3)Study completedNCT00236743What this trial is testingThe Effectiveness and Safety of Topiramate in the Treatment of Children With EpilepsyWho this might be right forEpilepsyEpilepsies, PartialSeizures Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 90
Large-scale testing (Phase 3)Looking for participantsNCT05135091What this trial is testingStudy of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))Who this might be right forMesial Temporal Lobe Epilepsy Neurona Therapeutics 88
Large-scale testing (Phase 3)Study completedNCT00280059What this trial is testingStudy Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial EpilepsyWho this might be right forEpilepsy, Partial Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 660
Large-scale testing (Phase 3)Study completedNCT01091662What this trial is testingSafety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current AntiepilepticWho this might be right forEpilepsy Sumitomo Pharma America, Inc. 172
Large-scale testing (Phase 3)Looking for participantsNCT07505004What this trial is testingDouble-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal SeizuresWho this might be right forFocal Epilepsy Praxis Precision Medicines 300
Testing effectiveness (Phase 2)Study completedNCT01338805What this trial is testingPhase II BGG492 Capsule Extension for Partial EpilepsyWho this might be right forPartial Onset Seizures Novartis Pharmaceuticals 56